D55.8 Other anemias due to enzyme disorders

Name of the Condition

• Other anemias due to enzyme disorders

Summary

Other anemias due to enzyme disorders are a group of hemolytic anemias caused by deficiencies in enzymes other than those specifically classified under glucose-6-phosphate dehydrogenase (G6PD) or glutathione metabolism disorders. These enzymatic deficiencies impair red blood cell metabolism, leading to premature destruction of red blood cells and reduced oxygen-carrying capacity. The condition results in symptoms of anemia and may be triggered by environmental or genetic factors.

Causes

The condition arises from genetic mutations that reduce or eliminate the activity of specific enzymes involved in red blood cell metabolism, such as pyruvate kinase or other glycolytic enzymes. These mutations are typically inherited and may be exacerbated by factors that increase oxidative stress or metabolic demand on red blood cells.

Risk Factors

• Genetic predisposition (inherited enzyme deficiencies)
• Exposure to oxidative stressors (e.g., certain medications, infections, or chemicals)
• Family history of hemolytic anemia
• Underlying metabolic disorders affecting red blood cell enzyme pathways

Symptoms

• Fatigue and weakness
• Pale skin or jaundice
• Shortness of breath
• Dark urine (in acute hemolysis)
• Rapid heart rate
• Enlarged spleen (splenomegaly)

Diagnosis

Diagnosis involves blood tests to assess red blood cell count, hemoglobin levels, and reticulocyte count, along with specific enzyme activity assays to identify the deficient enzyme. Additional tests may include hemoglobin electrophoresis or genetic testing to confirm the underlying enzymatic defect.

Treatment Options

Treatment focuses on managing hemolysis and addressing the underlying enzyme deficiency. This may include avoiding triggers (e.g., oxidative stressors), blood transfusions for severe anemia, and in some cases, splenectomy to reduce red blood cell destruction. Supportive care, such as folic acid supplementation, may also be recommended.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the enzyme deficiency and the presence of triggering factors. With appropriate management, many individuals can maintain a stable condition. Regular follow-up with a hematologist is important to monitor for complications and adjust treatment as needed.

Complications

• Severe anemia requiring transfusions
• Chronic fatigue or reduced quality of life
• Increased risk of infections
• Gallstones due to chronic hemolysis
• Splenomegaly or splenic rupture

Lifestyle & Prevention

• Avoid known triggers (e.g., certain medications, infections, or chemicals)
• Maintain a balanced diet rich in folic acid
• Stay hydrated and manage stress
• Follow up with a hematologist for regular monitoring

When to Seek Professional Help

Seek medical attention if you experience severe fatigue, jaundice, dark urine, or shortness of breath, as these may indicate acute hemolysis. Prompt evaluation is important to prevent complications and adjust treatment.

Tips for Medical Coders

When coding for D55.8, ensure documentation supports the specific enzyme disorder (e.g., pyruvate kinase deficiency) and excludes other specified anemias due to enzyme disorders. Verify that the diagnosis aligns with clinical findings and laboratory results to confirm the enzymatic deficiency.